News | July 23, 2025
Akums launches high-strength Paracetamol oral suspension 500mg/5ml
Akums bridges the long-standing gap between paediatric syrups and conventional tablet formats
Akums bridges the long-standing gap between paediatric syrups and conventional tablet formats
Amlodipine and Atorvastatin tablets are indicated in patients for whom treatment with both amlodipine and atorvastatin
Lonza’s new simplified and streamlined operating model is designed to support its One Lonza vision and strategy
Alembic Pharmaceuticals Ltd. and Amlan International sign exclusive strategic commercial agreement to make poultry health innovations accessible to Indian farmers and integrators
The product is being recalled because the infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL single-dose bag, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 m
According to IQVIATM sales data for the 12-month period ending October 2024, the Vimpat Oral Solution, 10 mg/mL market achieved annual sales of approximately $57.0 million
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies
Nelarabine is a nucleoside metabolic inhibitor indicated for the treatment of patients with T-cell acute lymphoblastic leukemia
Strides’ approval for this product marks the 1st Indian approval from the USFDA for this complex formulation
Aurigene.AI is an end-to-end solution for small molecule drug discovery
Subscribe To Our Newsletter & Stay Updated
